erythro-L-Isoleucine en es it fr

erythro-L-Isoleucine Brand names, erythro-L-Isoleucine Analogs

erythro-L-Isoleucine Brand Names Mixture

  • No information avaliable

erythro-L-Isoleucine Chemical_Formula


erythro-L-Isoleucine RX_link

No information avaliable

erythro-L-Isoleucine fda sheet

erythro-L-Isoleucine msds (material safety sheet) MSDS.pdf

erythro-L-Isoleucine Synthesis Reference

No information avaliable

erythro-L-Isoleucine Molecular Weight

131.174 g/mol

erythro-L-Isoleucine Melting Point

168-170 oC

erythro-L-Isoleucine H2O Solubility

No information avaliable

erythro-L-Isoleucine State


erythro-L-Isoleucine LogP


erythro-L-Isoleucine Dosage Forms

Capsules, powder, tablets

erythro-L-Isoleucine Indication

The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.

erythro-L-Isoleucine Pharmacology

They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert.

erythro-L-Isoleucine Absorption

Absorbed from the small intestine by a sodium-dependent active-transport process

erythro-L-Isoleucine side effects and Toxicity

Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs

erythro-L-Isoleucine Patient Information

No information avaliable

erythro-L-Isoleucine Organisms Affected

Humans and other mammals